Rabbit Polyclonal CLCC1 antibody. Suitable for IHC-P, IP, WB, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human CLCC1 aa 400 to C-terminus.
View Alternative Names
KIAA0761, MCLC, CLCC1, Chloride channel CLIC-like protein 1, ER anion channel 1, Mid-1-related chloride channel protein, ERAC1
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CLCC1 antibody (AB237755)
HeLa (Human epithelial cell line from cervix adenocarcinoma) cells stained for CLCC1 (green) using ab237755 at 1/100 dilution in ICC/IF, followed by an Alexa-Fluor®488 conjugated Goat Anti-Rabbit IgG (H+L).
The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal goat serum. The cells were then incubated with the primary antibody overnight at 4°C. Secondary used is an Alexa-Fluor®488-conjugated Goat Anti-Rabbit IgG (H+L). Counterstained with DAPI.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CLCC1 antibody (AB237755)
Paraffin-embedded human liver cancer tissue stained for CLCC1 using ab237755 at 1/400 dilution in immunohistochemical analysis.
After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30 minutes at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized tissue using an HRP conjugated SP system.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CLCC1 antibody (AB237755)
Paraffin-embedded human testis tissue stained for CLCC1 using ab237755 at 1/400 dilution in immunohistochemical analysis.
After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30 minutes at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized tissue using an HRP conjugated SP system.
- IP
Supplier Data
Immunoprecipitation - Anti-CLCC1 antibody (AB237755)
CLCC1 was immunoprecipitated from 500 μg HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate with ab237755 at 1/200 dilution.
Lane 1 : Rabbit control IgG IP in HepG2 whole cell lysate.
Lane 2 : ab237751 IP in HepG2 whole cell lysate.
Lane 3 : HepG2 whole cell lysate 20 μg (Input).
For western blotting, an HRP-conjugated Protein G antibody was used as the secondary antibody at 1/2000 dilution.
All lanes:
Immunoprecipitation - Anti-CLCC1 antibody (ab237755)
Predicted band size: 62 kDa
false
- WB
Supplier Data
Western blot - Anti-CLCC1 antibody (AB237755)
All lanes:
Western blot - Anti-CLCC1 antibody (ab237755) at 1/500 dilution
Lane 1:
COLO320 whole cell lysate
Lane 2:
U-251 MG (human brain glioma cell line) whole cell lysate
Lane 3:
HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate
Lane 4:
A549 (human lung carcinoma cell line) whole cell lysate
Lane 5:
HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate
Secondary
All lanes:
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 62 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
World journal of gastroenterology 29:3770-3792 PubMed37426316
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com